[CLSTR]
< Back to situations

[ORGANIZATION]

TriNetX

Featured in 7 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [US] [BR] [GB]

GLP-1 drugs: clinical trends, safety, and market shifts

315 clusters · 1160 sources · last updated

Latest: GLP-1 weight loss drugs drive surge in protein-based products

The clinical and economic landscape of GLP-1 medications continues to expand. Beyond obesity, research indicates potential benefits for psychiatric, respiratory, and neurodegenerative health. A large-scale U.S. study sug

[ACTIVE] [HEALTH] [US] [GB]

Statins and glaucoma risk association study

3 clusters · 19 sources · last updated

Latest: Statins linked to reduced risk of glaucoma, study finds

A large-scale observational study published in the British Journal of Ophthalmology has linked the use of statins, which are commonly prescribed to lower cholesterol, to a reduced risk of developing open-angle glaucoma.

[ACTIVE] [HEALTH] [US] [GB] [SE]

Expanding therapeutic uses and regulatory approvals for GLP-

33 clusters · 154 sources · last updated

Latest: GLP-1 medications show weight loss challenges regarding muscle mass and maintenance

Medical research continues to expand the therapeutic potential of GLP-1 receptor agonists like semaglutide and tirzepatide. While semaglutide is widely used for weight loss and diabetes, new evidence suggests it may slow

[QUIET] [HEALTH] [US] [GB] [AU]

Shingles trends and Shingrix vaccine research

8 clusters · 38 sources · last updated

Latest: Shingles vaccine demand rises amid potential dementia prevention links

Recent data indicates a significant rise in shingles cases among younger adults, particularly millennial women in the United States and the United Kingdom. Research shows that cases among adults aged 30–49 in the U.S. mo

Also covered in